Critical Considerations in the Biomedical Use of Mesoporous Silica Nanoparticles.
about
Re-examining the size/charge paradigm: differing in vivo characteristics of size- and charge-matched mesoporous silica nanoparticles.pH-responsive dual cargo delivery from mesoporous silica nanoparticles with a metal-latched nanogate.A reversible light-operated nanovalve on mesoporous silica nanoparticles.3D visualization of additive occlusion and tunable full-spectrum fluorescence in calcite.Degradation of the electrospun silica nanofiber in a biological medium for primary hippocampal neuron - effect of surface modification.Effects of Mesoporous Silica Coating and Post-Synthetic Treatment on the Transverse Relaxivity of Iron Oxide NanoparticlesSmart Mesoporous Nanomaterials for Antitumor Therapy.MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition.Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks.Noninvasive photothermal cancer therapy nanoplatforms via integrating nanomaterials and functional polymers.Mesoporous silica nanoparticles functionalized with fluorescent and MRI reporters for the visualization of murine tumors overexpressing αvβ3 receptors.Codelivery of anticancer drugs and siRNA by mesoporous silica nanoparticles.Biodegradable ZnO@polymer core-shell nanocarriers: pH-triggered release of doxorubicin in vitro.Composite Biomaterials Based on Sol-Gel Mesoporous Silicate Glasses: A Review.Location-tuned relaxivity in Gd-doped mesoporous silica nanoparticles.SPE and purification of DNA using magnetic particles.Redox- and temperature-controlled drug release from hollow mesoporous silica nanoparticles.On-chip evaluation of platelet adhesion and aggregation upon exposure to mesoporous silica nanoparticles.Photoluminescent ZnO Nanoparticles and Their Biological Applications.Preparation of aqueous colloidal mesostructured and mesoporous silica nanoparticles with controlled particle size in a very wide range from 20 nm to 700 nm.Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.A multifunctional role of trialkylbenzenes for the preparation of aqueous colloidal mesostructured/mesoporous silica nanoparticles with controlled pore size, particle diameter, and morphology.Oxygen Sensing with Perfluorocarbon-Loaded Ultraporous Mesostructured Silica Nanoparticles.Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights.The core contribution of transmission electron microscopy to functional nanomaterials engineering.The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.Redox-responsive degradable honeycomb manganese oxide nanostructures as effective nanocarriers for intracellular glutathione-triggered drug release.Ceramic Smart Drug Delivery NanomaterialsDesign of thermoresponsive polymeric gates with opposite controlled release behaviorsToward Correlation in In Vivo and In Vitro Nanotoxicology StudiesElectron microscopy for inorganic-type drug delivery nanocarriers for antitumoral applications: what does it reveal?Synthesis and Physicochemical Characterization of MesoporousSiO2Nanoparticles
P2860
Q30573652-BDAD7CB9-6603-4DE6-ADB5-A8F8D12D052BQ34580400-FC6F46E5-1CBC-42A8-BBE4-88BCC4880E3CQ35009134-A79FDAE4-D019-49E4-BF27-A02A0F2621DFQ36195833-66133E83-70FE-409A-859D-4F17709BEAF2Q36648818-CDDF66AD-A778-451E-B1C4-534036B04518Q36960523-9BA770C0-812C-4CA8-A408-FD75A0A6855AQ37638621-DF7F8095-D798-4819-B0D2-19388EE6461FQ38154210-F4AF6B08-8DFA-4AC4-BA43-08ADECE8FFA0Q38155457-4659F895-779A-4C99-B9D2-07DCF772A03CQ38205561-51637C60-01D2-4ABF-BDE9-BEB58479915EQ38271137-15025DFF-E903-48A0-B5E4-8329EC1EAE94Q38758605-0DDA4B22-3CD3-4113-83F9-AB5E57313BCAQ38781032-A348806D-1653-412D-B173-6E5E46101CFFQ38787542-1F776A12-9E24-4FF1-8672-06D7878CDA1BQ38943053-DA4E4277-66E9-466D-B3D8-0E2B0EA3DFDBQ39184856-29617BBE-EAD4-43C5-86D4-D29CD87B4813Q41513381-E89AAA2C-8EA7-434C-898F-7C6356AA0665Q42720452-5D4FC22C-7C02-48DA-BA17-049AC043F60DQ44329006-8E66FCFB-78BA-46E0-B6A7-E1B73CD3B07EQ45903832-BEB9FC16-E594-43B1-A143-C4EEA7BB635AQ46596056-25A43735-BAA8-4BFB-A198-E39C69B26FF1Q47143719-FBD76443-3E7A-4B84-9CB6-39078FE2515AQ47231926-9131394D-9E3C-4359-8179-25044611998AQ47295411-A6885728-A9A7-48C0-84F9-F5AC035DC1FEQ47349479-DC00BDA5-F7F1-457B-850F-81F932F84E91Q48143557-85AEF758-FE85-403C-8F8C-EB506C8851EDQ50163907-0E7D8554-C756-4221-A0C2-46414A4F0380Q51604278-E6FFF111-B9C2-4602-8F84-02DF8434D8B6Q51657611-24ED85B2-627A-478B-B423-E0EF2F7AA344Q53386285-1B067279-3B9E-4477-8E6B-065417A6AC2AQ57341243-27908AA6-D56C-4C27-A91C-1AD467546187Q57367172-E26802B1-A74C-4008-9985-46C5FFB30309Q57425298-F8CE122B-79A7-4466-98BA-6B31B96FA23DQ58139962-105A0FFA-8D60-4335-962F-DC16E280C677Q59058308-847C281C-9AEC-4D64-9AE2-0FE551F15C08
P2860
Critical Considerations in the Biomedical Use of Mesoporous Silica Nanoparticles.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Critical Considerations in the Biomedical Use of Mesoporous Silica Nanoparticles.
@en
type
label
Critical Considerations in the Biomedical Use of Mesoporous Silica Nanoparticles.
@en
prefLabel
Critical Considerations in the Biomedical Use of Mesoporous Silica Nanoparticles.
@en
P356
P1476
Critical Considerations in the Biomedical Use of Mesoporous Silica Nanoparticles.
@en
P2093
Katie R Hurley
Yu-Shen Lin
P304
P356
10.1021/JZ2013837
P577
2012-01-18T00:00:00Z